Tetrac; 67-30-1; Tetraiodothyroacetic acid; 3,3',5,5'-TETRAIODOTHYROACETIC ACID; T4-acetic acid; 2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid; 2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid; Benzeneacetic acid, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-; Thyroacetic acid, 3,3',5,5'-tetraiodo-; PA7UX1FFYQ; 3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid; 3,5,3',5'-Tetraiodo Thyroacetic Acid; Acide 3,5,3',5'-tetraiodothyroacetique; DTXSID5048186; 3,3,5,5-Tetraiodothyroacetic acid; Acetic acid, (4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)-; [4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid; [4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic Acid (Tetraiodothyroacetic Acid); T4A; UNII-PA7UX1FFYQ; EINECS 200-649-1; (4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)ACETIC ACID; 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid; 3,3',5,5'-TETRAIODOTHYRO-ACETIC ACID; Acide 3,5,3',5'-tetraiodothyroacetique [French]; Liothyronine Impurity D; Spectrum_000409; SpecPlus_000851; Spectrum2_000545; Spectrum3_000612; Spectrum4_000610; Spectrum5_001610; BSPBio_002144; KBioGR_001140; KBioSS_000889; DivK1c_006947; SCHEMBL365951; SPECTRUM1500775; SPBio_000589; CHEMBL549748; DTXCID5028160; KBio1_001891; KBio2_000889; KBio2_003457; KBio2_006025; KBio3_001644; CHEBI:131194; BDBM398043; US10322118, Entry 1; BCP33836; ZINC8681598; Tox21_303492; Benzeneacetic acid, 3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)-; CCG-39583; MFCD00055932; STL451043; AKOS027427106; CS-W009575; DB01751; HY-W008859; CAS-67-30-1; NCGC00095962-01; NCGC00095962-02; NCGC00257434-01; AS-76569; FT-0675069; T3730; D78468; Levothyroxine sodium impurity, t4-acetic acid-; LIOTHYRONINE SODIUM IMPURITY D [EP IMPURITY]; BRD-K71437774-001-02-3; LEVOTHYROXINE SODIUM IMPURITY D [EP IMPURITY]; Q27092911; 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetic acid; 2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)aceticacid; LEVOTHYROXINE SODIUM IMPURITY, T4-ACETIC ACID- [USP IMPURITY]